From GlobeNewswire: 2025-04-01 19:25:00

COSCIENS Biopharma Inc. announces the acceptance of their application for a management cease trade order by the Ontario Securities Commission. The MCTO was issued due to potential delays in filing required financial statements and reports, with a deadline extension to April 7, 2025. The MCTO restricts trading by the CEO and CFO until filings are complete, but does not affect other shareholders’ ability to trade. The company remains listed on the Nasdaq Capital Market, with plans to file necessary reports promptly. No material changes have occurred since the Default Announcement was made.



Read more at GlobeNewswire: COSCIENS Biopharma Inc. Announces Receipt of Management